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Abstract 
Objective Impaired inhibition may perpetuate repetitive symptoms in obsessive-compulsive disorder 
(OCD), however OCD-specific deficits have yet to be established. We investigated neural correlates of 
inhibition in OCD vs. healthy and anxious controls. Methods ERPs and reaction times (RTs) were 
compared between participants with OCD (n = 20), panic disorder (PD; n = 20) and healthy controls (HCs; 
n = 20) during an adapted Go/NoGo task, which manipulated inhibitory difficulty. Results A classic P3 
NoGo anteriorisation effect occurred across groups. Both clinical groups showed RT impairment, and 
similar topographical anomalies of several (P2, N2 and P3) ERP components. Notably, both clinical 
groups lacked the strong frontally maximal N2 component topography seen in the HCs, across stimuli. 
Additionally, with increasing inhibitory difficulty, N2 latency increased in HCs but not in the clinical groups. 
Conclusions Unexpectedly, ERP and behavioural anomalies during inhibition in OCD were not qualitatively 
different to those in PD, but were generally more severe. Common general and inhibitory deficits may 
underlie intrusive mental phenomena in both conditions. Significance This first ERP response inhibition 
study in OCD to include anxious controls disconfirmed hypotheses regarding OCD-specific inhibitory 
deficits, indicating the importance of comparing OCD to other conditions, to evaluate neurobiological 
models. 
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• We conducted the first event-related potential study of inhibitory processes in OCD to 
include an anxious comparison group, in the search for OCD-specific deficits. 
• As in previous studies of inhibition, participants with OCD showed RT impairment, 
and ERP anomalies during several (P2, N2, P3) information-processing stages, compared to 
healthy controls.  
• Surprisingly, deficits and ERP anomalies did not differ qualitatively between OCD 
and panic disorder, precluding OCD-specific interpretations and illustrating the importance of 
including clinical comparison groups in future research, to advance neurobiological models 




Objective: Impaired inhibition may perpetuate repetitive symptoms in obsessive-
compulsive disorder (OCD), however OCD-specific deficits have yet to be established. We 
investigated neural correlates of inhibition in OCD versus healthy and anxious controls.  
Methods: ERPs and reaction times (RTs) were compared between participants with 
OCD (n = 20), panic disorder (PD; n = 20) and healthy controls (HCs; n = 20) during an 
adapted Go/ NoGo task, which manipulated inhibitory difficulty.  
Results: A classic P3 NoGo anteriorisation effect occurred across groups. Both clinical 
groups showed RT impairment, and similar topographical anomalies of several (P2, N2 and P3) 
ERP components. Notably, both clinical groups lacked the strong frontally maximal N2 
component topography seen in the HCs, across stimuli. Additionally, with increasing inhibitory 
difficulty, N2 latency increased in HCs but not in the clinical groups.  
Conclusions: Unexpectedly, ERP and behavioural anomalies during inhibition in OCD 
were not qualitatively different to those in PD but were generally more severe. Common 
general and inhibitory deficits may underlie intrusive mental phenomena in both conditions.  
Significance: This first ERP response inhibition study in OCD to include anxious 
controls disconfirmed hypotheses regarding OCD-specific inhibitory deficits, indicating the 
importance of comparing OCD to other conditions, to evaluate neurobiological models.  
 





Current approaches to OCD implicate additional neurobiological processes in its 
aetiology compared to other anxiety disorders (Kuelz et al. 2004). Consequently, much 
research has focused on identifying OCD-specific neuropsychological deficits which may 
increase understanding of the pathophysiology underlying the disorder. While OCD has been 
linked to a wide variety of neuropsychological deficits, particularly in executive processing and 
inhibition, results are frequently inconsistent or are not replicated, and OCD-specific 
impairments have yet to be clearly established (Greisberg and McKay 2003; Kuelz et al. 2004; 
Simpson et al. 2006; Olley et al. 2007). The extent to which information-processing anomalies 
in OCD overlap with those in other anxiety disorders is central to ongoing considerations of the 
classification of OCD and its relationship to anxiety disorders versus other psychiatric 
conditions (Stein et al. 2010; Bienvenu et al. 2012). While ERP studies have allowed the 
nuanced study of inhibition in OCD, as with brain imaging studies (Rauch et al. 1997; van den 
Heuvel et al. 2005; Radua et al. 2010), ERP studies comparing OCD with other disorders are 
extremely rare (Oades et al. 1996; Schall et al. 1997; Miyata et al. 1998), limiting conclusions 
regarding OCD-specific deficits. 
Impaired sensorimotor inhibition, that is the ability to suppress task-irrelevant 
information and to restrain prepotent behavioural responses when they are inappropriate 
(Bjorklund and Harnishfeger 1995), has long been hypothesised to underlie repetitive 
symptoms in OCD and has been widely investigated. The Go/NoGo task is commonly used to 
investigate inhibitory processes, and requires withholding responses to infrequent “NoGo” 
stimuli presented amongst frequent “Go” stimuli requiring a motor response. Some Go/NoGo 
studies report impaired performance in OCD in the form of higher commission errors (Bannon 
et al. 2002; Bannon et al. 2008) or slower reaction times (RTs; Aycicegi et al. 2003), however 
most report no behavioural impairment in participants with OCD (Di Russo et al. 2000; 
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Johannes et al. 2001; Herrmann et al. 2003; Maltby et al. 2005; Roth et al. 2007; Bohne et al. 
2008). Studies using standard measures of inhibition have yet to build a consistent picture of 
deficits in OCD, possibly due to the use of non-specific experimental tasks and test batteries 
designed to indicate gross neuropsychological deficits which may not be sensitive to more 
subtle anomalies seen in psychiatric disorders such as OCD (Sanz et al. 2001; Kuelz, Hohagen 
et al. 2004). ERPs allow the study of subtle psychophysiological anomalies including those 
which are not accompanied by behavioural deficits.  
1.1 ERP studies of OCD  
ERP studies of OCD have usually employed auditory oddball tasks, which measure 
attention to standard (i.e. non-target) versus infrequent (i.e. target) stimuli. Differences between 
OCD and healthy controls are usually reported, however specific findings differ considerably. 
Differences in OCD relative to HCs include both larger (Towey et al. 1990; Towey et al. 1993) 
and smaller N2 amplitudes (Morault et al. 1997), and both larger P3a amplitude (Gohle et al. 
2008), and smaller P3 amplitude (Oades et al. 1996) have been reported. The inconsistent 
direction of findings may be due to differing task and stimulus complexity and may indicate a 
dysregulation (Morault et al. 1997) of N2 and P3 inhibitory processes rather than consistent 
under- or over-activation of specific components. Additionally, increased N1 latency has been 
reported in OCD, possibly indicating anomalies in stimulus discrimination (Morault et al. 
1997). Reduced N2 and P3 latencies are reported in several studies (Towey et al. 1990; 1993; 
Morault et al. 1997; Sanz et al. 2001; Kivircik et al. 2003), interpreted as a sign of cortical 
over-arousal in OCD which may be linked to inhibitory deficits and intrusive symptoms 
(Morault et al. 1997). Similar reduced 
Go/NoGo tasks are considered better measures of inhibitory processes (Falkenstein et 
al. 1999; Di Russo et al. 2000) because they establish pre-potent responding to Go stimuli, and 
therefore greater difficulty inhibiting responses to NoGo stimuli. When healthy individuals 
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withhold responses to NoGo stimuli, the N2 component is typically larger (Jodo and Kayama 
1992; Eimer 1993; Falkenstein et al. 1999), and the P3 component is generally larger and more 
frontally distributed (Roberts et al. 1994; Fallgatter and Strik 1999) than when they are 
responding to Go stimuli, interpreted as neurophysiological correlates of inhibitory processes. 
ERP latencies in Go/NoGo tasks are also related to inhibition. Longer P3 latency has been 
reported in NoGo compared to Go conditions, interpreted as a sign of higher processing 
demands in the NoGo condition (Fallgatter and Strik 1999; Salisbury et al. 2004). While studies 
primarily focus on the N2/P3 complex in the Go/NoGo task, modulations in earlier waveform 
components such as the P1, N1 or P2 may play major roles in determining inhibition success 
(Roche et al. 2005). 
Source analyses of ERP components during the Go/NoGo task indicate that the Go-P3 
originates in the bilateral parietal lobes, the NoGo-P3 sources are mainly in the inferior anterior 
cingulate cortex and lateral orbitofrontal area (Bokura et al. 2001), and the N2 component 
originates in medial orbitofrontal and cingulate cortices (Bokura et al. 2001; 2002; Bekker et al. 
2005). Because these regions are also implicated in the pathophysiology of OCD (Whiteside et 
al. 2004), the Go/NoGo task seems particularly suitable for the study of OCD. 
Two visual Go/NoGo studies (Malloy et al. 1989; Kim et al. 2007) report reduced 
anteriorisation of the N2 during the NoGo condition in OCD compared to controls. In one study 
this correlated negatively with Y-BOCS symptom severity, interpreted as a sign of inhibitory 
deficits (Kim et al. 2007). Another study, however, reported increased NoGo N2 amplitudes in 
OCD compared to healthy controls (Ruchsow et al. 2007). As with the oddball findings, the 
inconsistencies may be due to differing task and stimulus complexity and may indicate a 
dysregulation of N2 inhibitory processes which varies in direction (Morault et al. 1997). For the 
P3, Hermann et al. (2003) found reduced frontal NoGo amplitude and reduced NoGo 
anteriorisation in OCD, correlated negatively with YBOCs symptoms scores, again interpreted 
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as indicating inhibitory deficits. Di Russo et al. (2000) found increased frontal P3 amplitude in 
OCD patients to Go stimuli, relative to controls, with the OCD group having the same large P3 
activation to both Go and NoGo stimuli, interpreted as a misallocation of cognitive resources in 
OCD. With regard to latencies, one study found reduced N2 latencies to Go stimuli in OCD 
relative to healthy controls (Herrmann et al. 2003).  
Previous studies had small sample sizes of 8-13 OCD participants (Schall et al. 1997; 
Di Russo et al. 2000; Herrmann et al. 2003; Ruchsow et al. 2007). Malloy et al. (1989) had a 
larger sample of 18 OCD participants, however they analysed left side electrodes only. Only 
one study we located (Schall et al. 1997) used a clinical comparison group (schizophrenia), and 
there are apparently no studies in this area comparing OCD with an anxious control group, 
limiting conclusions about OCD-specific deficits. Sensorimotor inhibitory deficits occur in 
several psychiatric conditions, including attention-deficit hyperactivity disorder (Epstein et al. 
2001), bipolar disorder (Murphy et al. 1999), depression (Paradiso et al. 1997), schizophrenia 
(Braff 1993) and panic disorder (Ludewig et al. 2002; 2005), and further research is needed to 
investigate the specificity of effects to OCD.  
1.2 Additional methodological issues 
One interpretive difficulty which arises in traditional Go/NoGo tasks is that ERP 
differences may reflect the differential overlap of movement-related activity between Go and 
NoGo stimuli, rather than purely variations in cognitive inhibitory activity (Kopp et al. 1996; 
Falkenstein et al. 1999). We previously described a modified Go/NoGo task (Thomas et al. 
2009) which addressed the issue of differential Go/NoGo movement overlap by establishing 
four distinct categories of NoGo stimuli which had been differentially primed by preceding Go 
stimuli and varied in inhibitory difficulty but not in response requirements. Different categories 
of NoGo stimuli could therefore be compared as a function of inhibitory load, avoiding the 
necessity for Go/NoGo comparisons. Following an fMRI study, (Durston et al. 2002), we 
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predicted that inhibitory difficulty would be greater to NoGo stimuli preceded by larger 
numbers of Go stimuli. As predicted, ERP effects varied systematically according to the 
preceding context of stimuli. The traditional Go/NoGo analysis was also conducted, for 
comparison with a large body of previous literature (Thomas et al. 2009).  
In our previous study, increasing the numbers of preceding Go stimuli resulted in 
incremental increases in N1, P2 and N2 latencies, interpreted as an indication of greater 
inhibitory difficulty to NoGo stimuli as a function of preceding Go stimuli. ERP amplitudes 
showed more complex higher-order effects with indications of inhibition which reversed 
towards the end of longer stimulus trains, possibly due to anticipatory effects (Thomas et al. 
2009). Thus we established a means of comparing ERPs to stimuli associated with differing 
difficulty of inhibition, independent of motor confounds. Additionally, when we conducted the 
standard Go/NoGo comparison, well established Go-NoGo effects were replicated, suggesting 
that the modified task was comparable with previous Go/NoGo studies.   
1.3 Panic disorder 
Panic disorder is a common anxiety disorder which, like OCD, results in significant 
impairment in functioning. The neurobiology of panic disorder is not yet fully understood, 
however dominant models implicate both excessive activation, and impaired cortical inhibition, 
of anxiety-related caudal limbic neural circuits (Coplan and Lydiard 1998). The prefrontal 
cortex is also implicated in the core pathophysiology of panic disorder, with hypofrontality in 
imaging studies being interpreted to indicate executive dysfunction and impaired prefrontal 
cortical inhibition of hyperactivity of anxiety-related neural circuitry (Ohta et al. 2008). 
Individuals with panic disorder therefore constitute a suitable comparison group in the search 
for OCD-specific inhibitory deficits. 
1.4 The current study 
The current study used ERP and behavioural data to examine sensorimotor inhibition in 
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OCD, to establish the nature of inhibitory anomalies, and the extent to which they are OCD-
specific or shared with an anxiety disorder (PD). We used the experimental approach 
established earlier with a healthy sample (Thomas et al. 2009). ERP measures, RT and 
accuracy of responses were analysed to Go and NoGo stimuli in a standard Go/ NoGo 
comparison. Additionally, we manipulated the difficulty of inhibition by varying the number of 
Go stimuli which preceded NoGo stimuli. Forty clinical participants were recruited (20 with 
diagnoses of OCD and 20 with PD) for comparison with the ERP and performance data for the 
HCs previously reported (Thomas et al. 2009). 
We predicted atypical activation and/or topography of N2 and P3 components, and of 
the NoGo versus Go N2 and P3 components in OCD relative to HC. To support OCD-specific 
inhibitory deficits, the OCD group should differ from both the healthy and anxious control 
groups. Additionally, we predicted that comparison of NoGo stimuli differentially negatively 
primed by preceding Go stimuli would provide further insight into inhibitory processes and that 
the OCD group would show atypical ERP latencies with increasing difficulty of inhibition in 
comparison to HC and anxious controls.  
2. Method 
2.1 Participants 
Forty individuals participated in the current study: 20 with OCD and 20 with PD with or 
without agoraphobia. Their data were compared with those of 20 HCs reported in our previous 
study (Thomas et al. 2009). The data for the clinical groups were collected contemporaneously 
with those for the healthy controls, in the same lab with identical testing procedures and 
recording instrumentation. Because the clinical participants took longer to recruit, as is often 
the case, we finished recruitment for the healthy controls earlier than the clinical groups. 
Because of the novel nature of the methodology, we considered that it was important to first 
publish a report which considered performance and neural correlates during this task in healthy 
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participants, as a foundation for later interpreting the complex between-group analysis.  
No individuals in the PD group had a personal or known family history of OCD or 
obsessive-compulsive symptoms. Clinical participants were recruited through local clinics. 
Diagnoses were confirmed using the Composite International Diagnostic Interview for DSM-
IV (World Health Organisation 1997). While some participants were prescribed occasional 
benzodiazepines (Table 1), none had taken benzodiazepines in the preceding 48 hours. HCs 
were free from past or present psychiatric disorders. Exclusion criteria across groups were head 
injuries, neurological disorders, substance abuse and psychoses. The University of Wollongong 
Ethics Committee approved the research protocol beforehand and participants gave written 
informed consent. 
2.2 Materials 
Symptom types and severity were assessed using the Padua Inventory-Washington State 
University Revision (PI-WSUR (Burns et al. 1996), the Yale-Brown Obsessive Compulsive 
Scale (Goodman et al. 1989), the Brief Symptom Inventory (BSI; Derogatis and Melisaratos 
1983) and Obsessional Beliefs Questionnaire (OBQ-44; Obsessive Compulsive Cognitions 
Working Group 1997; 2001; 2005). 
2.3 Stimuli 
Stimuli were presented individually on a computer screen in white on a black 
background. They comprised a baseline stimulus (!), a Go stimulus (), and a NoGo stimulus 
(X). Two further stimuli were included for future comparisons of task-switching performance 
and are not examined here (X-Go and dedicated NoGo), following at the end of stimulus trains. 
Stimuli occurred in sequences or trains of 4-8 (See Figure 1.). Trains commenced with the 
baseline stimulus, followed by between 1-4 Go stimuli (), followed by a NoGo stimulus (X). 
The X-NoGo stimulus was followed on 50% of trials by a repetition of the X-stimulus (because 
participants were required to respond to X-repetitions, this stimulus is termed X-Go) and on 
11 
 
50% of trials by a square (dedicated NoGo stimulus). Thus a NoGo (N) stimulus occurred in 
each train, but because N was preceded by one or more Go-stimuli, the overall ratio of Go: 
NoGo stimuli presented to participants was 14:4 or 69%: 31%. Train types were equiprobable 
and presented randomly. Stimulus duration was 200 ms. ISI varied randomly between 1-3 s 
(mean 2 s) and inter train interval varied randomly between 4-6 s. Overall, 635 stimuli were 
presented to participants in 70 trains. 
2.4 Procedure 
After completing interviews and questionnaires, participants were fitted with the 
electrode cap. During the experiment participants were comfortably seated in a dimly lit sound-
attenuated room, 1m from the computer screen, with a button-press device fixed to a chair arm 
next to their dominant hand.  
2.5 Electrophysiological recording 
The EEG was recorded from 19 scalp electrodes (F1, F2, F3, Fz, F4, F7, F8, T3, T4, T5, 
T6, C3, Cz, C4, P3, Pz, P4, O1, O2) and referenced to linked ears according to the international 
10 – 20 system (Jasper, 1958) using tin electrodes in an electrode cap. The participant was 
grounded by a cap electrode located midway between Fpz and Fz. Vertical EOG was recorded 
from electrodes placed 1 cm above and below the left eye, and electrodes placed beyond the 
outer canthus of each eye recorded horizontal EOG. Electrode impedances were below 5kΩ. 
2.6 Data analysis 
One-way analyses of variance (ANOVAs) were used to compare groups on age and 
psychometric variables. Significant differences between groups were followed by simple 
effects comparisons to investigate which group differences were driving the effects. Fisher’s 
exact test was used to compare group categorical variables.  
Mean RTs for correct responses by stimulus type were calculated for each participant in 
each task. Extreme scores (± 2 SDs from the participant's condition mean) were excluded 
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(Ratcliff, 1993; Thomas et al. 2009). A one-way ANOVA was used to compare groups on RTs 
to Go stimuli. Effects of the number of preceding Go stimuli upon commission errors to NoGo 
stimuli were analysed using a 3 Group (HC, PD, OCD) x 4 Stimulus sequence position (GN, 
GGN, GGGN, GGGGN) ANOVA. As described above, planned contrasts assessed linear and 
quadratic effects for the Stimulus sequence position factor.   
The ERP epoch was defined as 100 ms pre- to 800 ms post-stimulus. ERP data were 
amplified with EEG and EOG gains of 20,000 and 5,000 respectively, digitized at a sampling 
rate of 512 Hz with a bandpass down 3 dB at 0.01 and 35 Hz, and filtered offline with a low 
pass zero phase shift filter at 30 Hz, 48dB/octave. Data were accepted after artifact rejection 
(±100μV) and eye-movement correction (Semlitsch et al. 1986).  
Five components were quantified, with amplitudes determined relative to the 100 ms 
pre-stimulus baseline. Peaks were automatically detected in specified channels where they 
generally showed maximal amplitude in the grand mean waveforms: O1 for P1 (50–140ms); 
O2 for N1 (90–160 ms); Pz for P2 (150 - 210 ms); Fz for N2 (180 - 400 ms), and Pz for P3 
(290 - 600 ms). Search windows were based on visual inspection of the grand mean 
waveforms. Following automatic detection, individual peaks were visually inspected and 
manually confirmed or corrected. Eleven sites were the focus of data analysis (F3, Fz, F4, C3, 
Cz, C4, P3, Pz, P4, O1, O2). ERP latencies were recorded as the time during the search window 
of maximal amplitude at the index channel, and the component amplitudes for all 11 electrodes 
were taken at the same post-stimulus latency (Picton et al. 2000). 
 Within the lateral plane, two planned contrasts were computed: left versus right 
hemispheres, and the midline region versus the mean of the left and right hemispheres. The 
contrasts for the Sagittal factor were: (i) frontal vs. parietal electrodes and (ii) central vs. the 
mean of the frontal and parietal electrodes. As the contrasts were planned and there were no 
more of them than the degrees of freedom for an effect, no Bonferroni-type adjustment was 
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necessary (Tabachnick et al. 2001). Greenhouse–Geisser corrections were applied where 
appropriate. ERP data were normalised using the vector scaling procedure (McCarthy and 
Wood 1985), and interactions involving topography are reported only if they remained 
significant after normalisation.  
To assess whether any Group effects or interactions may have been related to 
medication status, for each clinical group separately, analyses were repeated as above with a 
between group factor of Medication, with 2 levels (no medication, current medication). 
Interactions and effects are only reported if no involved factor interacted with Medication.  
3. Results   
3.1 Group characteristics and psychometric variables 
Tables 1 shows that there were no significant differences between groups for 
demographic variables. Table 2 shows psychometric results, with the OCD group having higher 
scores than the HC group on all measures of psychopathology. There were no significant 
differences between the OCD and PD groups on measures of psychological symptoms, except 
that the OCD group scored significantly higher on OCD symptoms (measured by the Padua 
Inventory). The PD group scored higher than the HC group on all measures of 
psychopathology, except in OCD symptoms.   
3.2 Behavioural results 
Table 3 shows behavioural data across groups. There were no interactions between 
Medication and performance. There was an effect of Group on RT, F (2, 57) = 4.27, p = .02, 
with both clinical groups having longer RTs than the HC group (OCD vs. HC: F (1, 38) = 5.48, 
p = .025; PD vs. HC: F (1, 38) = 8.72, p = .005; PD vs. OCD: F (1, 38) = 1.5, p = .7). Accuracy 
of responses to NoGo stimuli (NoGo-X) was high (99.9%) and did not differ by Group or as a 
function of Go preceding NoGo stimuli. 
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3.3 ERPs to Go versus NoGo stimuli 
Table 4 shows all significant ERP effects and interactions involving Group, and 
accompanying two-group comparisons. Grand mean waveforms to Go and NoGo stimuli are 
shown in Figure 2. Mean ERPs to Go stimuli and NoGo (NoGo-X) stimuli were compared in a 
Stimulus (Go, NoGo) x Sagittal (frontal, central, parietal) x Lateral (left, midline, right) x 
Group (HC, PD, OCD) ANOVA. For N1 amplitude, an additional ANOVA was conducted at 
occipital electrodes (O1, O2) with factors of Group (as above) x Stimulus type (as above) x 
Lateral (left, right).  
P1 amplitude was larger to NoGo than Go stimuli, F (1, 57) = 18.6, p < .001, and had a 
greater central (versus fronto-parietal) effect to NoGo than Go stimuli, F (1, 57) = 11.27, p < 
.01.  
N1 amplitude was greater fronto-parietally (versus centrally) to NoGo than Go stimuli, 
F (1, 57) = 7.78, p < .01. N1 amplitude was greater at lateral (vs. midline) sites, with this effect 
being greater for NoGo compared to Go stimuli, F (1, 57) = 20.04, p < .01. N1 latency was 
faster to Go than NoGo stimuli, F (1, 57) = 4.3, p < .05.  
P2 amplitude was larger, F (1, 57) = 7.18, p < .01, and showed a stronger parietal > 
frontal effect, F (1, 57) = 6.92, p < .05, to NoGo than Go stimuli. P2 latency was faster to Go 
than NoGo stimuli, F (1, 57) = 9.39, p < .01.  
For N2, the Group by Sagittal interaction was significant, F (2, 57) = 3.28, p < .05, with 
both clinical groups having the same atypical topography of N2 amplitude across Go and NoGo 
stimuli, and an absence of the frontal > parietal topography seen in the HCs. N2 amplitude was 
greater centrally (versus fronto-parietally) to NoGo than Go stimuli, F (1, 57) = 6.81, p < .05. 
N2 latency was faster to Go than NoGo stimuli, F (1, 57) = 8.54, p < .01.  
P3 amplitude was larger to NoGo than Go stimuli, F (1, 57) = 4.04, p < .05. P3 
amplitude showed a stronger frontal (vs. parietal) effect to NoGo than Go stimuli (i.e. a NoGo 
anteriorisation effect), F (1, 57) = 5.35, p < .05 and a greater central (versus fronto-parietal) 
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effect to NoGo than Go stimuli, F (1, 57) = 28.57, p < .001. P3 latency was faster to Go than 
NoGo stimuli, F (1, 57) = 5.94, p < .05. 
3.4 ERPs to NoGo stimuli as a function of preceding sequence  
Mean ERPs to NoGo stimuli as a function of the number of preceding Go stimuli are 
shown in Figure 4. ERPs to NoGo stimuli were analysed using an ANOVA with Group x 
Stimulus sequence (GN, GGN, GGGN, GGGGN) x Sagittal x Lateral factors as above. For N1 
amplitude, an additional ANOVA was conducted at occipital electrodes (as before). Because 
the focus of the current study is between-group differences, only interactions involving Group 
are reported here. A detailed consideration of sequence effects in the current experimental 
approach appears elsewhere (Thomas et al. 2009). Mean ERP amplitudes to NoGo stimuli for 
significant Group effects and interactions are plotted in Figure 5, and latencies in Figure 6. 
P1 amplitude showed a Group by Laterality (linear) interaction, F (2, 57) = 4.4, p < .05, 
driven by increased right versus left hemisphere amplitude for P1 to NoGo stimuli in the PD 
versus OCD and HC groups.  
N1 amplitude showed a Group by Laterality (linear) interaction, F (2, 57) = 3.3, p < .05, 
driven by reduced N1 amplitude in the left versus right hemisphere to NoGo stimuli in PD 
relative to HCs (Table 4). Table 4 shows a main effect of Group for N1 latency, F (2, 57) = 
6.84, p < .01, driven by significantly longer N1 latencies to NoGo stimuli in the OCD than HC 
group (Figure 6). 
For P2, a main effect of Group, F (2, 57) = 3.97, p < .05, and simple effects showed that 
the OCD group had significantly smaller P2 amplitude to NoGo stimuli than HCs. A Group by 
Sagittal interaction, F (2, 57) = 12.08, p < .01, and simple effects showed that the OCD group 
had significantly reduced parietal versus frontal P2 amplitude to NoGo stimuli compared to HC 
and PD groups. This effect was also present in the PD group relative to HCs.  
For N2, a Group by Sagittal (frontal vs. parietal) interaction for N2 amplitude to NoGo 
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stimuli, F (2, 57) = 5.21, p < .01, and simple effects showed a stronger frontal > parietal effect 
for N2 amplitude to NoGo stimuli in HCs than OCD and PD groups. N2 latency showed a main 
effect of Group, F (2, 57) = 3.51, p < .05, with the PD group having shorter N2 latencies than 
the OCD and HC groups. The Stimulus (linear) by Group interaction, F (2, 57) = 4.41, p < .05, 
was significant, driven by both clinical groups failing to show the increase in N2 latency as a 
function of Go preceding NoGo stimuli evidenced by the HCs.  
P3 amplitude showed a significant Group by Sagittal (frontal vs. parietal) interaction, F 
(2, 57) = 5.51, p < .01. Simple effects analyses indicated atypical topography of P3 amplitude 
in both clinical groups, with reduced parietal versus frontal P3 compared to HCs.   
3.5 Relationships between experimental effects and symptoms 
We conducted selective Pearson correlations to examine relationships between the 
above significant effects and symptom severity as measured by the Y-BOCS, the BSI (Anxiety, 
Obsessive-compulsive and Depression subscales, Global Severity Index and Positive Symptom 
Distress Index), the PI-WSUR, and the OBQ-44.  
RT to Go stimuli was positively correlated with Y-BOCS Obsessions, r (20) = .50, p < 
.05, and Compulsions, r (20) = .49, p < .05. For ERPs, only correlations significant at the 0.01 
level are reported. N2: Right parietal amplitude to NoGo stimuli was negatively correlated to 
BSI Anxiety, r (60) = -.34. Left parietal amplitude to Go stimuli negatively correlated to OBQ 
total, Responsibility/Threat, Importance/Control of Thoughts, Thoughts of harm, BSI OC, 
Anxiety, Global Severity Index, Positive Symptom Total and Positive Symptom Distress Index, 
r (60) between -.34 and -.43. Midline parietal amplitude to Go stimuli negatively correlated to 
OBQ total, r (60) = -.34, and Importance/ Control of Thoughts, r (60) = -.41. Right parietal 
amplitude to Go stimuli negatively correlated to OBQ Importance/ Control of Thoughts, r (60) 
= -.41, BSI Anxiety, r (60) = -.37 and BSI Positive Symptom Total, r (60) = -.34. For P3, 




Current models of OCD implicate additional neurobiological processes compared to 
other anxiety-related disorders (e.g., Kuelz et al. 2004). While numerous ERP studies have 
attempted to identify neuropsychological factors which may increase understanding of the 
pathophysiology of OCD, very few have included clinical comparison groups, thus limiting 
conclusions about OCD-specific deficits. The current study addressed these limitations by 
including an anxious comparison group with PD, having similar levels of symptom severity but 
without any personal or family history of OCD. Although there have been several previous 
studies of neural activity accompanying response inhibition in OCD, to our knowledge this was 
the first to include an anxious comparison group. Additionally, we employed a specially 
modified Go/NoGo task (Thomas et al. 2009) which included an additional examination of 
inhibitory processes which avoided some of the interpretive limitations when comparing Go 
with NoGo stimuli. This task allowed the comparison of different groups of NoGo stimuli with 
each other which were differentially primed by preceding Go stimuli, and therefore differed in 
inhibitory difficulty while not having the response requirement differences inherent in Go/ 
NoGo comparisons.  
4.1 Go/Nogo Comparison 
When we followed the well-established method of comparing ERPs to Go versus NoGo 
stimuli, P3 amplitude was larger and showed a stronger frontal (vs. parietal) effect to NoGo 
than Go stimuli (i.e. a classic NoGo anteriorisation effect), across groups. This is consistent 
with previous OCD studies (e.g. Kim et al. 2007), and indicates that the task was comparable to 
existing Go/NoGo studies, with NoGo stimuli being associated with ERP responses typically 
interpreted as indexing brain inhibitory mechanisms (Roberts et al. 1994; Fallgatter and Strik 
1999) in both the clinical and healthy groups.  
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Both clinical groups, however, showed remarkably similar atypical topography of N2 
across stimuli, with more posteriorly distributed N2 amplitudes and an absence of the strong 
frontally maximal topography seen in the HC group. Additionally, greater negativity of N2 in 
parietal regions was related to several measures of psychopathology including obsessional 
beliefs, obsessive-compulsive symptoms, anxiety, and overall severity of psychological 
symptoms and distress. This was localised to the right hemisphere for NoGo stimuli but 
occurred across left, midline and right parietal sites to Go stimuli.  
Previously, Kim et al. (2007) also reported a more posteriorly distributed NoGo N2 in 
OCD compared to controls, correlated with symptom severity, which they interpreted as 
indicating inhibitory deficits in OCD, possibly induced by dysfunctions of the inferior 
prefrontal cortex and contributing to the pathophysiology of OCD. Also, a more posteriorly 
distributed NoGo N2 has been reported in children relative to adults, interpreted to indicate the 
effortful recruitment of more primitive brain regions, such as the striatum, for inhibitory control 
before the prefrontal brain regions are fully mature (Ciesielski et al. 2004; Jonkman et al. 
2007). In the current study this posteriorly distributed N2 negativity occurred across Go and 
NoGo stimuli, suggesting a general processing anomaly such as a misallocation of cognitive 
resources noted in previous OCD studies (Di Russo et al. 2000), rather than purely an 
inhibitory deficit. Posterior shifts in N2 topography have been linked to the effects of 
noradrenaline release on cortical processing (Warren et al. 2011). It is possible that the atypical 
N2 topography reflects recruitment of additional cortical areas in task performance in the 
clinical groups, linked to catecholamine release, however further research is needed. 
Occurrence of the same pattern of topographical abnormalities in participants with panic 
disorder and no history of OCD militates against an OCD-specific interpretation.  
Consistent with previous research, N1, P2, N2 and P3 latencies were prolonged to 
NoGo compared to Go stimuli across groups, likely indicating the higher processing demands 
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involved in inhibiting, compared to executing, anticipated actions (Fallgatter and Strik 1999). 
Both clinical groups had general RT slowing to Go stimuli. RT impairment in participants with 
OCD was positively related to (Y-BOCS) symptom severity. Longer RTs to Go stimuli have 
been reported previously in OCD relative to HCs (Aycicegi et al. 2003), however many studies 
find no impairment (Di Russo et al. 2000; Johannes et al. 2001; Herrmann et al. 2003; Roth et 
al. 2007; Bohne et al. 2008). Reviews of neuropsychological performance in OCD (Kuelz et al. 
2004; Olley, Malhi et al. 2007) conclude that task performance is often at a similar overall level 
to controls, but is accompanied by longer RTs in about half the studies, indicating that accuracy 
may be accomplished at a cost to speed. Medication status did not interact with RTs in the 
current study, and it is therefore concluded that both anxious groups showed general RT 
slowness associated with clinical status. This interpretation was supported by the correlation 
between P3 latency to Go stimuli and BSI Anxiety severity, suggesting that clinical anxiety 
was associated both with slower cognitive as well as motor responses to Go stimuli. In 
summary of the Go versus NoGo results, this is to our knowledge the first ERP Go/NoGo study 
which included an anxious comparison group, and no OCD-specific inhibitory or general 
deficits were detected.  
4.2 Inhibitory load manipulation 
The current study also manipulated the difficulty of withholding responses to NoGo 
stimuli by varying the number of preceding Go stimuli. By comparing NoGo stimuli of varying 
inhibitory difficulty we could examine the neural correlates of inhibition while avoiding the 
interpretive difficulties inherent in Go/ NoGo comparisons, such as motor movements 
overlapping ERPs to a greater extent for Go than NoGo stimuli (Kopp et al. 1996; Falkenstein 
et al. 1999). We initially trialed this modified Go/NoGo task in healthy participants and found 
that increasing the number of Go stimuli before NoGo stimuli led to ERP indications of greater 
inhibitory difficulty including incremental increases in N1, P2 and N2 latencies (Thomas et al. 
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2009). Because the aim of the current study was to identify OCD-specific inhibitory deficits, 
we focus here on between-group differences. Further information about sequence effects in this 
task as a result of experimental manipulations is considered in more detail elsewhere (Thomas 
et al. 2009).  
In the current study, both anxious groups failed to show the increase in N2 latency as a 
function of the number of Go preceding NoGo stimuli evidenced by the HCs. Towey et al. 
(1993) reported that increasing task difficulty resulted in longer N2 and P3 latencies in HCs, 
but not in OCD patients in an auditory oddball task. A defining feature of inhibitory brain 
processes is a decrement (in speed or accuracy) resulting from previous stimulation (Posner and 
Snyder 1975; Buckner et al. 1998; Klein 2000), and longer ERP latencies to NoGo than Go 
stimuli are attributed to higher processing demands when withholding than executing 
anticipated actions (Fallgatter and Strik 1999; Herrmann et al. 2003; Salisbury et al. 2004). The 
N2 ERP component is considered a key neurophysiological aspect of response inhibition 
processes (Kaiser et al. 2006). Failure of both anxious groups to show the increase in N2 
latency evidenced by the HCs with increasing inhibitory load may indicate anomalous brain 
inhibitory mechanisms in both clinical groups. 
The OCD group had longer N1 latencies to NoGo stimuli than the HCs. N1 latency 
increases with increased attention to stimuli, and with effort at processing (Callaway and 
Halliday 1982). One previous ERP Go/NoGo study reported longer N1 latency to Go stimuli in 
OCD (Di Russo et al. 2000) while others found no significant differences between control and 
OCD ERP latencies (Malloy et al. 1989; Schall et al. 1997; Herrmann et al. 2003; Ruchsow et 
al. 2007). Longer N1 latencies in OCD were also reported in an oddball task (Morault et al. 
1997). The current findings may indicate slower or more effortful early discriminative 
processing (Oades et al. 1996) in OCD.  
Participants with OCD had smaller P2 amplitude, particularly parietally, to NoGo 
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stimuli relative to HCs. The P2 is interpreted as representing stimulus discrimination and 
classification (Dowman 2004) and inhibitory processes (Coburn et al. 2005) and is affected by 
vigilance and arousal (Oades et al. 1996). Reduced P2 latency has been linked to weakness of 
inhibition (Muller and Roberts 2005). Smaller P2 amplitudes have previously been reported in 
participants with OCD, relative to HCs and those with schizophrenia, during an auditory 
oddball task (Oades, Zerbin et al. 1996). P2 amplitude increases with faster, more accurate 
performance in Go/NoGo tasks (Johnstone et al. 2001), suggesting that it is related to stimulus 
evaluation processes underlying optimal performance. Several studies demonstrate a 
dependence of P2 amplitude on serotonin activity (Norra et al. ; Hegerl and Juckel 1993; 
Hegerl et al. 2001; Juckel et al. 2003; Senkowski et al. 2003; Juckel et al. 2008). Serotonin 
dysregulation is implicated in the pathogenesis of OCD (Hesse et al. 2005; Baca-Garcia et al. 
2007; Lin 2007; Goddard et al. 2008; Perani et al. 2008; Matsumoto et al. 2010) and anxiety 
disorders generally, including panic disorder (Coplan and Lydiard 1998; Bandelow et al. 2008). 
It is therefore notable that the PD group showed intermediate P2 amplitude between the HCs 
and OCD group, and shared P2 topographical anomalies with OCD relative to the HCs. In a 
previous study, participants with PD had reduced P2 amplitude to non-targets, compared to 
healthy controls (Wang et al. 2003). Taken in conjunction with previous research, the current 
P2 results may indicate shared anomalies in arousal, vigilance or inhibition in OCD and panic 
disorders. 
In the current study, both clinical groups also shared atypical topography of the NoGo 
P3, with lower parietal relative to frontal amplitude compared to HCs. Lower parietal P3, 
which improves after treatment with SSRIs, has been previously reported in OCD, interpreted 
as a sign of general cognitive and inhibitory dysfunction (Sanz et al. 2001). Additionally, 
higher frontal cortical activation in OCD has been noted in several studies (reviewed in Saxena 
and Rauch 2000). These patterns are typically interpreted within a model of OCD-specific 
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posterior cortical under-activation and anterior cortical over-activation of a primary or 
compensatory nature (Ciesielski et al. 2005; Menzies et al. 2008). The current results, however, 
indicate that abnormalities in parietal activation are not OCD-specific but common to PD. 
Additionally, the P3 results must be viewed in the context that in the current study both clinical 
groups showed increased parietal negativity across several (P2, N2 and P3) information-
processing stages. Parietal brain regions are increasingly implicated in both OCD (Ciesielski et 
al. 2005; Menzies et al. 2008) and PD (Alemayehu et al. 1995; Heller et al. 1997; Bisaga et al. 
1998), and the current results support the consideration of their role in information-processing 
in these disorders.   
4.3 Summary and integration 
Overall, participants with OCD showed several significant differences from HCs in 
performance and ERP measures in the Go/NoGo task. Similar anomalies have been reported in 
previous ERP studies of OCD, including RT impairment (see Kuelz et al. 2004; Olley et al. 
2007), more posteriorly distributed N2 amplitude (Kim et al. 2007), a failure to show 
increasing N2 latency with increasing task difficulty (Towey et al. 1993), longer N1 latencies to 
NoGo stimuli (Di Russo et al. 2000) and smaller P2 amplitude (Oades, Zerbin et al. 1996).  
Surprisingly, however, with the inclusion of an anxious comparison group in the current 
study, we found that participants with PD showed remarkably similar performance and ERP 
anomalies to the OCD group. For most effects, the OCD group differed significantly only from 
the HCs and the PD group showed an intermediate effect. There were only two findings where 
the OCD group differed significantly from both the HC and PD groups. The first was greater 
scores on measures of OCD symptoms (e.g. Padua) in the OCD than other groups, as would be 
predicted. The second was a reduced parietal: frontal topography of P2 to NoGo stimuli, 
however the PD group showed this same atypical topography and also differed significantly 
from the HCs for this effect, suggesting that the same underlying processes were present in 
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both clinical conditions, but were more pronounced in OCD than in PD.  
The current pattern of results leads to the suggestion that general and inhibitory 
anomalies in the current study are not OCD-specific but may represent common abnormalities 
among these disorders. Additionally, it highlights the need for caution in interpreting the results 
of studies of OCD without anxious control groups. The only previous ERP study of which we 
are aware to include an anxious control group found N2 abnormalities in OCD versus HCs in 
an oddball task for target and non-target stimuli, with N2 negativity for a social phobic 
comparison group falling halfway between, supporting a similar interpretation.  
These findings have implications for understanding the extent to which OCD is 
associated with unique deficits and psychophysiological activity relative to panic disorder. The 
extent to which pathological processes in OCD overlap with anxiety disorders such as PD has 
important nosological and clinical implications. Very few previous studies of brain activity in 
OCD included anxious control groups, including the majority of neuroimaging studies upon 
which neurobiological models of OCD (e.g. Saxena and Rauch 2000; Whiteside, Port et al. 
2004) have been developed. Inclusion of a PD group showing equivalent levels of symptom 
severity and medication status led to results which are more consistent with conceptualisations 
of a considerable overlap in the neural substrates of OCD with PD rather than with models 
emphasising a unique neural signature in OCD (Mataix-Cols and van den Heuvel 2006). The 
overlapping ERP and behavioural results during response inhibition in the current study may be 
related to other shared phenomena between the two disorders. Both OCD and PD share 
symptoms of anxiety and behavioural avoidance, although with different foci and 
manifestations (Miyata et al. 1998; Bartz and Hollander 2006). For both conditions, first line 
treatments include SSRIs and tricyclic antidepressants (TCAs), often with higher doses in 
OCD, and cognitive behavioural therapy (CBT). Both disorders are characterised by failures to 
inhibit irrelevant and repetitive stimuli (Amir et al. 2001; Wise et al. 2009).   
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These results support recent observations that the tendency to study OCD in isolation 
from other disorders may have been an important barrier to progress in determining OCD-
specific versus general (disorder nonspecific) etiologic factors (Taylor 2012). If an inhibitory 
deficit is not specific to OCD, its importance in aetiological theories declines because it cannot 
be a necessary and sufficient cause of the disorder (see Nigg 2000). 
4.4 Caveats and future directions 
Some clinical participants were prescribed medication at the time of testing. Previous 
ERP studies of OCD include medicated participants (Malloy et al. 1989; Sanz, Molina et al. 
2001; Herrmann et al. 2003; Ruchsow et al. 2007; Bohne et al. 2008; Hashimoto et al. 2008), 
which may be due to difficulties in recruiting research participants with OCD (Muller and 
Roberts 2005) as well as practical and ethical difficulties in finding off-medication patients 
(Clark et al. 2009). We addressed confounds of comparing a medicated clinical group with 
drug- naïve healthy controls by the inclusion of a clinical comparison group, taking similar 
levels and types of medications and differing significantly only on measures of OCD. Data 
were also reanalysed with medication as a between-subjects factor and found no interaction 
between medication status and any performance variables or ERP latencies. There were a small 
number of interactions between ERP amplitude topography or stimulus type and medication, 
and these results were excluded from reporting, reducing the likelihood of medication effects 
accounting for the current results. Nonetheless it is possible that medications influenced the 
results. 
As in most OCD ERP research the current study examined inhibitory processes to 
neutral stimuli only. Because individuals with OCD do not complain of global inhibitory 
deficits, but struggle to inhibit personally repugnant thoughts (Moritz et al. 2009), there is a 
need to investigate inhibition in relation to affective stimuli. Indeed there is some evidence of 
disorder-specific neural activity to affective stimuli between individuals with OCD and those 
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with panic disorder (van den Heuvel, Veltman et al. 2005; Thomas et al. 2013). 
4.5 Conclusions 
In the current study, ERP and behavioural anomalies in OCD during a response 
inhibition task were not qualitatively different to those in PD but were generally more severe. 
Previous research may have overestimated the specificity of deficits to OCD, due to a lack of 
clinical comparison groups. Additionally, the extent of inhibitory deficits in PD may have been 
inadequately explored. The current study highlights the need for further research using anxious 
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Legend of figures 
Figure 1. Example of a stimulus train with four Go stimuli. A baseline stimulus (!) is followed by 1-4 
go stimuli, and a NoGo stimulus (X-NoGo). These stimuli were followed by either another Go 
stimulus (X-Go) or dedicated NoGo stimulus (square), which are not examined here. 
Figure 2. Grand mean waveforms to Go versus NoGo stimuli, by group. 
Figure 3. Mean N2 amplitude across Go and NoGo stimuli, by Sagittal plane and Group.   
Figure 4. Grand mean waveforms to NoGo stimuli as a function of the number of 
immediately preceding Go stimuli in trains (GN-GGGGN), by Group. Note: x axis ticks = 
100ms; y axis indicates stimulus onset. 
Figure 5. Mean ERP amplitudes to NoGo stimuli for significant Group effects and 
interactions. Top left: P1 amplitude by lateral plane and Group: Top right; N1 amplitude 
by Lateral plane and Group: Middle left: P2 amplitude by Group: Middle right: P2 
amplitude by Sagittal plane and Group: Bottom right. N2 amplitude by Sagittal plane and 
Group: Bottom right: P3 amplitude by Sagittal plane and group. 
Figure 6. Mean ERP latencies (ms) to NoGo stimuli for significant Group effects and 
interactions. Left: N1 latency by Group. Right: N2 latency to NoGo stimuli by number of 
preceding Go stimuli (GN-GGGGN) and Group. 
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Table1. Participant demographic characteristics  
 
Variable   HC  
(n = 20) 
PD 
(n = 20) 
OCD  







        
        
Mean age  33 (± 13) 38 (± 12) 39 (± 14) Ns Ns Ns 
        
Gender Female 13 17 11 Ns Ns Ns 
        
Handedness Right handed 18 17 16 Ns Ns Ns 
        
Medication  SSRI 0 6 8 - - - 
        
 SNRI 0 0 2 - - - 
        
 RIMA 0 0 1 - - - 
        
 TCA 0 1 0 - - - 
        
 Occasional 
benzodiazepine 
0 1 1 - - - 





0 2 0 - - - 
        
 Total on 
psychotropic 
medication 
0 10 12 *** Ns *** 
* p < .05, ** p < .01, *** p < .001. SSRI – selective serotonin reuptake inhibitors; SNRI- Serotonin- 
norepinephrine reuptake inhibitors; RIMA- Reversible Inhibitor of Monoamine-Oxidase-A. 
Table 1
Table 2. Scores in psychometric questionnaires, by group.  
 
Variable  HC 
(n = 20) 
PD 
(n = 20) 
OCD 
(n = 20) 







           
  M (±) M (±) M (±)   - - -  
           
Yale Brown  
Obsessive-Compulsive Scale  
(Y-BOCS) 
 
Obsessions - - 14 (6)   - - -  
          
Compulsions - - 12 (6)   - - -  
          
Y-BOCS Total - -   26 (12)   - - -  
           
Brief symptom  
inventory (BSI) 
Depression subscale  .59 (1) 1.41 (1) 1.61 (1)   ** Ns *  
          
Phobic anxiety subscale .3 (1) 1.86 (2) 1.57 (1)   *** Ns ***  
          
Obsessive-Compulsive subscale    1.01 (1) 1.7 (1) 1.87 (1)   * Ns Ns  
          
Anxiety subscale .53 (1) 1.9 (1) 2.1 (1)   *** Ns ***  
          
BSI Global Severity Index  .6 (1) 1.46 (1) 1.6 (1)   ** Ns **  




Obsessional Beliefs  
Questionnaire (OBQ-44) 
 
Total Padua score 13 (11) 20 (14) 49 (33)   *** *** Ns 
















          
Perfectionism/ certainty 55 (20) 67 (23) 74 (23)   * Ns Ns  
          
Importance/ control of thoughts 28 (10) 39 (19) 49 (13)   *** Ns Ns  
        
OBQ-44 Total score 133 (43) 170 (56) 195 (53)   *** Ns Ns  
  
           
* p < .05, ** p < .01, *** p < .001. Note: the Y-BOCS, a measure of OCD severity, was only administered to the OCD group. 





Table 3. Mean RT (Ms) and percentage of errors by stimulus type, serial position and group. 
GN-GGGN indicates NoGo stimuli preceded by one-four Go stimuli respectively.  
 










Go RT (SD) 394 (63) 458 (85) 448 (90) 
% Errors (SD) .03 (.1) .03 (.05) .01 (.02) 
NoGo Errors (SD) .03 (.1) .03 (.05) .01 (.02) 
GN Errors (SD) .09 (.1) .12 (.3) .01 (.01) 
GGN Errors (SD) .09 (.09) .15 (.29) .08 (.1) 
GGGN Errors (SD) .07 (.08) .11 (.29) .05 (.09) 
GGGGN Errors (SD) .05 (.07) .12 (.3) .03 (.06) 
Baseline 
stimulus 
Errors (SD) 0.2 (.4) 0.25 (.8) 0.3 (.7) 
 
Table 3
Table 4. ANOVA probabilities for significant overall Group effects and interactions and two-group 
comparisons.  
Analysis Measure Contrast  ANOVA 
(P-value) 















        





P1 amplitude Group by Laterality 
(linear) 
0.017 0.621 0.021 0.024 
 N1 amplitude Group by Laterality 
(linear) 
0.044 0.104 0.023 0.414 
 N1 latency Group main effect 0.002 0.001 0.002 0.436 
 P2 amplitude Group main effect 0.000 0.000 0.015 0.019
 
 
 N2 amplitude Group by Sagittal 
(linear) 
0.008 0.013 0.017 0.871 
  latency Group by stimulus 0.019 0.025 0.007 0.678 
  latency Group main effect 0.017 0.655 0.008 0.041 
 P3 amplitude Group by Sagittal 
(linear) 
0.006 0.004 0.019 0.711 
 
 
 
 
Table 4
